BRIEF published on 08/04/2025 at 16:33, 8 months 5 days ago The Vanguard Group Discloses Position in Mitie Group plc Takeover Code Securities Disclosure Stock Purchase Vanguard Group Mitie Group Plc
PRESS RELEASE published on 08/04/2025 at 16:28, 8 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: Mitie Group plc The Vanguard Group, Inc. discloses a 5.01% interest in Mitie Group plc. Purchase of 2.5p ordinary shares disclosed. Date of disclosure: 04-Aug-2025 Vanguard Group Financial Disclosure Share Purchase Interest Disclosure Mitie Group Plc
BRIEF published on 07/31/2025 at 16:19, 8 months 9 days ago The Vanguard Group Discloses Position in Mitie Group plc Disclosure Takeover Code Vanguard Group Shareholding Mitie Group
PRESS RELEASE published on 07/31/2025 at 16:14, 8 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Mitie Group plc The Vanguard Group, Inc. discloses a 4.85% interest in Mitie Group plc. No other party involved. Dealings include purchase of 6,260 securities at 1.37 GBP per unit Vanguard Group Share Purchase Securities Dealing Interest Disclosure Mitie Group Plc
BRIEF published on 07/30/2025 at 16:30, 8 months 10 days ago The Vanguard Group Discloses Significant Stake in Mitie Group Vanguard Group Financial Disclosure Shareholding Equity Interest Mitie Group
PRESS RELEASE published on 07/30/2025 at 16:25, 8 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: Mitie Group plc The Vanguard Group, Inc. discloses 4.85% stake in Mitie Group plc as of 29 July 2025 Disclosure The Vanguard Group Stake Mitie Group Plc 4.85%
BRIEF published on 07/28/2025 at 16:08, 8 months 12 days ago The Vanguard Group Discloses Position in Mitie Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Mitie Group
PRESS RELEASE published on 07/28/2025 at 16:03, 8 months 12 days ago Form 8.3 - The Vanguard Group, Inc.: Mitie Group plc The Vanguard Group, Inc. discloses a 4.85% stake in Mitie Group plc as of 25 July 2025, with 13,783 securities purchased at 1.41 GBP per unit Vanguard Group Inc. Financial Disclosure Stake Disclosure Securities Purchase Mitie Group Plc
BRIEF published on 07/25/2025 at 15:48, 8 months 15 days ago The Vanguard Group Discloses Major Stake in Mitie Group Takeover Code Vanguard Group Shareholding Stake Disclosure Mitie Group
PRESS RELEASE published on 07/25/2025 at 15:43, 8 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Mitie Group plc The Vanguard Group, Inc. reveals 4.85% stake in Mitie Group plc. Disclosure complies with Rule 8.3 of Takeover Code Disclosure Rule 8.3 Takeover Code Vanguard Group Mitie Group Plc
Published on 04/09/2026 at 16:00, 2 hours 52 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 4 hours 12 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 4 hours 52 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 5 hours 22 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:30, 5 hours 22 minutes ago ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel
Published on 04/09/2026 at 18:15, 36 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 15:40, 3 hours 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 15:39, 3 hours 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/09/2026 at 18:35, 17 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 15:57, 2 hours 54 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 11 hours 52 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
